The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Jacobio Pharmaceuticals Group Co., Ltd. ( ($HK:1167) ) has issued an announcement. Jacobio Pharmaceuticals has announced significant progress in ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

The company’s focus will be on progressing the clinical validation of its idiopathic pulmonary fibrosis treatment.

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Despite this, it has won four new contracts and hailed a 'strong pipeline' as the firm branches out into antibody drug conjugates and looks to support clients in new phases of drug development. An ...

Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, ...

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, ...

The table below is a review of notable updates that occurred in February 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.